ID   BP(p)Tu
AC   CVCL_WN39
DR   Wikidata; Q93430547
RX   PubMed=8302588;
RX   PubMed=20135361;
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Simple; p.Lys130Arg (c.389A>G); Zygosity=Homozygous (PubMed=8302588).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WN38 ! BP
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
RX   PubMed=8302588;
RA   Le Rhun Y., Duthu A., Ehrhart J.-C., Michiels F., May E., May P.;
RT   "Directional selection associated with clonal expansion of p53 mutant
RT   cells during neoplastic development of carcinogen-treated rat embryo
RT   lung epithelial cells.";
RL   Oncogene 9:263-271(1994).
//
RX   PubMed=20135361; DOI=10.1007/s11626-009-9269-3;
RA   Yamada Y., Nakata A., Yoshida M.A., Shimada Y., Oghiso Y., Poncy J.-L.;
RT   "Implication of p16 inactivation in tumorigenic activity of
RT   respiratory epithelial cell lines and adenocarcinoma cell line
RT   established from plutonium-induced lung tumor in rat.";
RL   In Vitro Cell. Dev. Biol. Anim. 46:477-486(2010).
//